The Centre for Doctoral Training (CDT) in Advanced Therapeutics and Nanomedicines is a partnership of The University of Nottingham and University College London (UCL). This collaboration gives students the chance to be trained at the cutting-edge of pharmaceutical science at two highly rated universities.
The CDT is funded by the Engineering and Physical Sciences Research Council (EPSRC), offering 12 places - six at each university - and lasts four years.
The programme is based on three themes:
- systems-based pharmaceutics
- novel materials/processes
- advanced pharmaceutical analysis
Students gain pharmaceutical science knowledge through a range of training methods and industrial placements, working together with top pharmaceutical industrial partners and small and medium-sized enterprises (SMEs) such as:
- Alliance Boots
- Quotient Clinical
This course gives students the opportunity to understand the pharmaceutical industry on a global level, and to undertake international placements at university and industry partner sites abroad.
Visit the CDT website for full details.
The Centre for Doctoral Training in Advanced and Targeted Therapeutics is funded by the the Engineering and Physical Sciences Research Council.
Visit the Engineering and Physical Sciences Research Council (EPSRC) website to check eligibility requirements.
First-class or upper-second-class honours degree (or international equivalent) or a masters degree in a relevant discipline.